Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Dr. Copland's lab creates cell lines to mimic properties of original tumor tissue and preclinical cell models that will pave the way for future cancer treatment.
Dr. Copland's lab uses whole-genome-wide expression analysis to profile human carcinomas and identify aberrant signaling pathways.
Dr. Copland's lab examines RhoB and FoxO3a signaling in anaplastic thyroid carcinoma and other aggressive cancers.
The lab studies SCD1's role as a novel molecular target for the treatment of renal cell carcinoma and as a predictive biomarker for therapy in patients with renal cell carcinoma.
Dr. Copland's lab tests drug therapies that manipulate novel genes and proteins in combinations that are specific to the subtype of human cancers.
Dr. Copland's lab collaborates with numerous other researchers from Mayo Clinic, the U.S. and abroad.
Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.